Binh Dinh Pharmaceutical and Medical Equipment JSC (HOSE: DBD)

DBD Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	1,694,143	1,651,770	1,554,821	1,558,504	1,256,952	1,261,729
Revenue Growth (YoY)	1.30%	6.24%	-0.24%	23.99%	-0.38%	-9.94%
Cost of Revenue	875,785	853,250	787,170	935,939	765,813	846,933
Gross Profit	818,358	798,520	767,652	622,566	491,139	414,796
Selling, General & Admin	516,517	501,538	494,312	405,437	309,356	254,046
Operating Expenses	516,517	501,538	494,312	405,437	309,356	254,046
Operating Income	301,841	296,982	273,339	217,129	181,783	160,750
Interest Expense	-4,338	-6,998	-1,916	-1,325	-6,589	-10,314
Interest & Investment Income	10,142	11,635	8,733	5,137	7,056	12,932
Earnings From Equity Investments	24,819	28,704	24,786	16,083	15,238	14,439
Currency Exchange Gain (Loss)	-40.85	-482.96	354.16	733.11	-1,276	-263.59
Other Non Operating Income (Expenses)	-8,541	-9,753	-6,739	-5,310	-3,021	-3,530
EBT Excluding Unusual Items	323,882	320,086	298,558	232,448	193,191	174,013
Gain (Loss) on Sale of Investments	-2,000	-	-	-	-	-
Pretax Income	321,882	320,086	298,558	232,448	193,191	174,013
Income Tax Expense	48,397	51,031	55,003	43,324	35,332	31,786
Net Income	273,486	269,055	243,555	189,124	157,860	142,227
Preferred Dividends & Other Adjustments	37,668	37,668	34,098	26,477	18,943	14,223
Net Income to Common	235,818	231,387	209,457	162,646	138,916	128,005
Net Income Growth	-5.36%	10.47%	28.78%	19.80%	10.99%	-12.75%
Shares Outstanding (Basic)	94	94	94	94	94	94
Shares Outstanding (Diluted)	94	94	94	94	94	94
Shares Change (YoY)	-0.00%	-	-	-0.07%	-0.01%	-
EPS (Basic)	2520.67	2473.29	2238.88	1738.52	1483.83	1367.17
EPS (Diluted)	2520.67	2473.29	2238.88	1738.52	1483.83	1367.17
EPS Growth	-7.48%	10.47%	28.78%	17.16%	8.53%	-12.75%
Free Cash Flow	172,960	160,298	82,184	62,932	153,173	-150,664
Free Cash Flow Per Share	1848.77	1713.42	878.47	672.68	1636.12	-1609.19
Dividend Per Share	-	-	1600.000	-	839.161	839.161
Gross Margin	48.31%	48.34%	49.37%	39.95%	39.07%	32.88%
Operating Margin	17.82%	17.98%	17.58%	13.93%	14.46%	12.74%
Profit Margin	13.92%	14.01%	13.47%	10.44%	11.05%	10.15%
Free Cash Flow Margin	10.21%	9.70%	5.29%	4.04%	12.19%	-11.94%
EBITDA	345,299	340,193	315,005	255,818	213,592	188,695
EBITDA Margin	20.38%	20.60%	20.26%	16.41%	16.99%	14.96%
D&A For EBITDA	43,457	43,211	41,665	38,689	31,809	27,945
EBIT	301,841	296,982	273,339	217,129	181,783	160,750
EBIT Margin	17.82%	17.98%	17.58%	13.93%	14.46%	12.74%
Effective Tax Rate	15.04%	15.94%	18.42%	18.64%	18.29%	18.27%
Revenue as Reported	1,694,143	1,651,770	1,554,821	1,558,504	1,256,952	1,261,729

Source: S&P Capital IQ. Standard template. Financial Sources.